Imhoff John E sold GTHP
February 27, 2026 · Form 4 insider transaction
Imhoff John E sold 100 shares of Guided Therapeutics, Inc., a transaction worth N/A. The trade was recorded as j and disclosed on an SEC Form 4.
Direction
Disposed (sell-side)
Shares
100
Price
N/A
Total value
N/A
InsiderImhoff John E
RoleDirector, 10% owner
SecurityPreferred Series E Stock
Transaction codeJ: J
Transaction dateFebruary 27, 2026
Filing dateMarch 12, 2026
Shares owned after0
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
On February 27, 2026, Mr. Imhoff converted 100 shares of Series E preferred stock into 400,000 shares of common stock. The Series E preferred stock had a stated value of $1,000 and $0.25 conversion price.